1. Home
  2. AMS vs COCP Comparison

AMS vs COCP Comparison

Compare AMS & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Shared Hospital Services

AMS

American Shared Hospital Services

HOLD

Current Price

$2.14

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.06

Market Cap

15.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMS
COCP
Founded
1980
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2M
15.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMS
COCP
Price
$2.14
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
7.7K
103.2K
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,423,000.00
N/A
Revenue This Year
$3.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
17.84
N/A
52 Week Low
$2.01
$0.90
52 Week High
$3.21
$2.67

Technical Indicators

Market Signals
Indicator
AMS
COCP
Relative Strength Index (RSI) 52.97 48.68
Support Level $2.08 $1.00
Resistance Level $2.20 $1.19
Average True Range (ATR) 0.05 0.06
MACD -0.00 -0.00
Stochastic Oscillator 59.26 22.68

Price Performance

Historical Comparison
AMS
COCP

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: